GlassScriptPhysician profile
Eon K Shin
NPI 1841228608
$43,877.77
in general payments reported to CMS, 2019-2025
24 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,635 · 2020: $8,596 · 2021: $9,517 · 2022: $20K · 2023: $1,942 · 2024: $715 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $2,323 · Food and Beverage: $471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $2,322.69 |
| Food and Beverage | $470.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $19,588.12 | 2021-2024 | Avenger Radial Head, +4 Stems |
| Synthes USA Products LLC | $11,979.77 | 2020-2022 | |
| Integra Lifesciences Corporation | $5,465.04 | 2019-2022 | |
| In2bones USA, LLC | $2,400.00 | 2020-2021 | |
| Medical Device Business Services, INC. | $2,340.00 | 2019 | |
| Checkpoint Surgical, INC | $1,200.00 | 2020-2021 | |
| Axogen | $106.74 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $92.22 | 2019-2024 | Xiaflex |
| Stryker Corporation | $81.38 | 2023-2024 | Hoffmann, Gravity Synchfix |
| Acumed LLC | $78.81 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $72.38 | 2024-2025 | |
| Depuy Synthes Sales INC. | $69.84 | 2021-2024 | Anspach Helix |
| Anika Therapeutics, INC. | $64.77 | 2022 | |
| Orthofix Medical, INC. | $62.63 | 2021-2025 | Physio-Stim, Accelstim |
| Smith+Nephew, INC. | $58.51 | 2024-2025 | Oasis Micro, Stravix Pl, Q-Fix |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $51.95 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $26.89 | 2023 | Seglentis |
| Zimmer Biomet Holdings, INC. | $26.02 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $25.59 | 2025 | Wainua |
| Pacira Pharmaceuticals Incorporated | $23.11 | 2024 | Exparel |
| Djo, LLC | $19.23 | 2019 | |
| Medartis INC. | $18.05 | 2019 | |
| Endo USA, INC. | $16.11 | 2024 | Xiaflex |
| Electronic Waveform Lab, INC. | $10.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eon Shin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.